09.04.2015 Views

ABSTRACTS from 16th International COnference on ... - CRRT Online

ABSTRACTS from 16th International COnference on ... - CRRT Online

ABSTRACTS from 16th International COnference on ... - CRRT Online

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<str<strong>on</strong>g>ABSTRACTS</str<strong>on</strong>g> FROM 17 TH INTERNATIONAL CONFERENCE ON <strong>CRRT</strong>,<br />

SAN DIEGO, FEB 14-17, 2012<br />

Although not statistically significant,<br />

there appears to be differences in<br />

NGAL, KIM-1, OPN and albumin at<br />

different days between those with AKI<br />

and those without AKI. C<strong>on</strong>clusi<strong>on</strong>s:<br />

Urinary biomarkers can predict AKI<br />

term ne<strong>on</strong>ates with perinatal depressi<strong>on</strong><br />

independent of gestati<strong>on</strong>al age.<br />

30. Preventi<strong>on</strong> of Acute Kidney Injury<br />

in Hospitalized Children with<br />

Cystic Fibrosis<br />

David Askenazi, Adam W Scott,<br />

LaCrecia J Britt<strong>on</strong>, Hector Gutierrez,<br />

Raym<strong>on</strong>d Lyrene<br />

University of Alabama at Birmingham<br />

Introducti<strong>on</strong>: Aminoglycosides (AGs)<br />

are comm<strong>on</strong>ly used to treat cystic<br />

fibrosis (CF) related lung infecti<strong>on</strong>s.<br />

AGs are nephrotoxic and are an<br />

important risk factor for acute kidney<br />

injury (AKI) in hospitalized CF patients.<br />

In June 29, a new clinical protocol was<br />

implemented to reduce the incidence of<br />

AKI by standardizing m<strong>on</strong>itoring and<br />

AG treatment in all CF patients admitted<br />

to Children’s Hospital of Alabama for<br />

pulm<strong>on</strong>ary exacerbati<strong>on</strong>s. Hypothesis:<br />

We hypothesized that the incidence of<br />

AKI in hospitalized children with CF<br />

would decrease after the implementati<strong>on</strong><br />

of this clinical protocol. Methods: A<br />

retrospective chart review was<br />

performed using data <str<strong>on</strong>g>from</str<strong>on</strong>g> the<br />

UAB/Children’s of Alabama’s Cystic<br />

Fibrosis Center database and hospital<br />

records for all admissi<strong>on</strong>s of CF patients<br />

with pulm<strong>on</strong>ary exacerbati<strong>on</strong>s <str<strong>on</strong>g>from</str<strong>on</strong>g> July<br />

27 to April 211.These data include<br />

demographics, co-morbidities, and<br />

serum creatinines (SCr). Hospitalized<br />

costs were obtained <str<strong>on</strong>g>from</str<strong>on</strong>g> the Children’s<br />

of Alabama for cost analysis. AKI was<br />

defined as a rise in SCr of .3 mg/dl or<br />

5% rise <str<strong>on</strong>g>from</str<strong>on</strong>g> a baseline value, according<br />

to the 211 Kidney Disease Improving<br />

Global Outcomes (KDIGO) AKI<br />

definiti<strong>on</strong>. Data analysis was performed<br />

using SPSS® software. IRB approval for<br />

the study was obtained. Results: The<br />

incidence of AKI was lower in the preprotocol<br />

group 96/ 631 (15.2%)<br />

compared to the post-protocol group<br />

113/ 475 (23.8%) (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!